Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10871)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2018 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Antonelli E, Villanacci V, Bassotti G. Novel oral-targeted therapies for mucosal healing in ulcerative colitis. World J Gastroenterol 2018; 24(47): 5322-5330 [PMID: PMC6305528 DOI: 10.3748/wjg.v24.i47.5322] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i47/5322.htm |
| Number | Citing Articles |
| 1 |
Liya Song, Pengfei Chen, Jin Yu, Xiaolu Han, Yabing Hua, Shan Liu, Bo Pang, Jing Gao, Jiahua Ma, Liang Xu. A novel cyanoacrylate-based matrix excipient in HPMCP capsules forms a sustained intestinal delivery system for orally administered drugs with enhanced absorption efficiency. Journal of Materials Chemistry B 2021; 9(5): 1288 doi: 10.1039/D0TB02606A
|
| 2 |
Rasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel-Reheim, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I. E. Adam, Lobna A. Saleh, Azza I. Farag, Elsayed A. Elmorsy, Hend S. El-Wakeel, Ahmed S. Doghish, Mohamed E. Shaker, Sara H. Hazem, Heba A. Ramadan, Rabab S. Hamad, Osama A. Mohammed. Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1239025
|
| 3 |
Ji Sang Lee, So Hee Kim. Dose-Dependent Pharmacokinetics of Tofacitinib in Rats: Influence of Hepatic and Intestinal First-Pass Metabolism. Pharmaceutics 2019; 11(7): 318 doi: 10.3390/pharmaceutics11070318
|
| 4 |
Axel Dignass, John Waller, Joseph C. Cappelleri, Irene Modesto, Agnes Kisser, Lena Dietz, Marco DiBonaventura, Robert Wood, Melanie May, Berit Libutzki, Danielle Bargo. Living with ulcerative colitis in Germany: a retrospective analysis of dose escalation, concomitant treatment use and healthcare costs. Journal of Medical Economics 2020; 23(4): 415 doi: 10.1080/13696998.2019.1707210
|
| 5 |
Elisabetta Antonelli, Gabriele Torti, Gabrio Bassotti. Inhibitors of the Janus Kinases. Journal of Clinical Gastroenterology 2019; 53(9): 635 doi: 10.1097/MCG.0000000000001250
|
| 6 |
Changming Zhang, Dong Ming, Gang Ji. Mucosal Healing Research Advances of Inflammatory Bowel Disease. Journal of Contemporary Medical Practice 2024; 6(9): 164 doi: 10.53469/jcmp.2024.06(09).30
|
| 7 |
Sung Hun Bae, Sun-Young Chang, So Hee Kim. Slower Elimination of Tofacitinib in Acute Renal Failure Rat Models: Contribution of Hepatic Metabolism and Renal Excretion. Pharmaceutics 2020; 12(8): 714 doi: 10.3390/pharmaceutics12080714
|
| 8 |
Hong Liu, Jianhua Cao, Benjamin Balluff, Audrey C.H.M. Jongen, Marion J. Gijbels, Jarno Melenhorst, Ron M.A. Heeren, Nicole D. Bouvy. Examination of lipid profiles in abdominal fascial healing using MALDI-TOF to identify potential therapeutic targets. Journal of Mass Spectrometry and Advances in the Clinical Lab 2021; 20: 35 doi: 10.1016/j.jmsacl.2021.06.002
|
| 9 |
Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
|
| 10 |
Giuseppe Leoncini, Simona Ronchetti, Rachele Del Sordo, Vincenzo Villanacci. Miscellaneous Considerations in Inflammatory Bowel Disease. 2024; doi: 10.5772/intechopen.1004729
|
| 11 |
Haider Rasheed Alrafas, Philip B. Busbee, Mitzi Nagarkatti, Prakash S. Nagarkatti. Resveratrol Downregulates miR‐31 to Promote T Regulatory Cells during Prevention of TNBS‐Induced Colitis. Molecular Nutrition & Food Research 2020; 64(1) doi: 10.1002/mnfr.201900633
|
| 12 |
Bo Cheng, Ai-mei Rong, Wenlu Li, Xiuqian Bi, Xinguang Qiu, Veedamali S. Subramanian. DNMT3a-Mediated Enterocyte Barrier Dysfunction Contributes to Ulcerative Colitis via Facilitating the Interaction of Enterocytes and B Cells. Mediators of Inflammation 2022; 2022: 1 doi: 10.1155/2022/4862763
|
| 13 |
Lie Zheng, Sheng-Lei Duan. Molecular regulation mechanism of intestinal stem cells in mucosal injury and repair in ulcerative colitis. World Journal of Gastroenterology 2023; 29(16): 2380-2396 doi: 10.3748/wjg.v29.i16.2380
|
| 14 |
Lauren C Chartier, Gordon S Howarth, Debbie Trinder, Suzanne Mashtoub. Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer. Carcinogenesis 2021; 42(2): 202 doi: 10.1093/carcin/bgaa099
|
| 15 |
El-Shaimaa A. Arafa, Wafaa R. Mohamed, Dana M. Zaher, Hany A. Omar. Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways. Toxicology and Applied Pharmacology 2020; 391: 114919 doi: 10.1016/j.taap.2020.114919
|
| 16 |
Giuseppe LEONCINI, Luca REGGIANI-BONETTI, Gloria SIMONCELLI, Vincenzo VILLANACCI. Histology of IBD and related colitides in the elderly. Minerva Gastroenterology 2024; 70(1) doi: 10.23736/S2724-5985.21.02888-6
|
| 17 |
Taraneh Mousavi, Shokoufeh Hassani, Maryam Baeeri, Mahban Rahimifard, Faezeh Vakhshiteh, Mahdi Gholami, Elmira Ghafour-Broujerdi, Mohammad Abdollahi. Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitis. Food and Chemical Toxicology 2022; 170: 113509 doi: 10.1016/j.fct.2022.113509
|
| 18 |
Gerardo Cazzato, Anna Colagrande, Valeria Andriola, Teresa Lettini, Sebastiano Cicco, Pragnell Mary Victoria Candance, Leonardo Resta, Leonardo Vincenti, Giuseppe Ingravallo. Histological Hallmarks of Mucosal Healing in Inflammatory Bowel Diseases in the Era of Monoclonal Antibodies Therapy: New Insights and Perspectives. Diagnostics 2021; 11(9): 1570 doi: 10.3390/diagnostics11091570
|
| 19 |
Yajing Zhang, Yilei Guo, Qin Zhang, Yanrong Zhu, Yufeng Xia, Zhifeng Wei, Yue Dai. Diallyl Trisulfide, a Major Bioactive Constituent of Garlic, Promotes Colonic Mucosal Healing in Ulcerative Colitis through Accelerating Focal Adhesion Assembly and Consequent Epithelial Cell Migration via the Rab21‐Integrin β1‐Fak Pathway. Molecular Nutrition & Food Research 2023; 67(12) doi: 10.1002/mnfr.202200784
|
| 20 |
Qinghui Jia, Haihua Zhang, Yongmei Su, Xin Liu, Jiangsong Bai, Wuying Lang, Qiumei Shi, Minshan Feng. Strictosamide alleviates the inflammation in an acute ulcerative colitis (UC) model. Journal of Physiology and Biochemistry 2021; 77(2): 283 doi: 10.1007/s13105-021-00796-y
|
| 21 |
Huanhuan Zhu, Shaopeng Tong, Yan Cui, Xiaodong Wang, Minying Wang. Tanshinol alleviates ulcerative colitis by promoting the expression of VLDLR. Drug Development Research 2021; 82(8): 1258 doi: 10.1002/ddr.21840
|
| 22 |
Jonathan Skupsky, Subrata Sabui, Michael Hwang, Manando Nakasaki, Michael D. Cahalan, Hamid M. Said. Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation. Cellular and Molecular Gastroenterology and Hepatology 2020; 9(4): 557 doi: 10.1016/j.jcmgh.2019.11.011
|
| 23 |
Sami Hoque, Amy Puenpatom, Simona Boccaletti, Chloe Green, Christopher M Black, Jenna Roberts, Ivana Rajkovic, Gary Milligan. Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience. BMJ Open Gastroenterology 2020; 7(1): e000476 doi: 10.1136/bmjgast-2020-000476
|
| 24 |
Ji Eun Kim, Mun Young Park, So Hee Kim. Simple determination and quantification of tofacitinib, a JAK inhibitor, in rat plasma, urine and tissue homogenates by HPLC and its application to a pharmacokinetic study. Journal of Pharmaceutical Investigation 2020; 50(6): 603 doi: 10.1007/s40005-020-00490-z
|
| 25 |
Changming Zhang, Dong Ming, Gang Ji. Mucosal Healing Research Advances of Inflammatory Bowel Disease. Journal of Contemporary Medical Practice 2024; 6(9): 175 doi: 10.53469/jcmp.2024.06(09).32
|
| 26 |
Fang Li, Qingsong Fei, Dan Mao, Qiaoyun Si, Manman Dai, Qun Ma, Huimin Zhang, Luyu Bai, Ning He. Comparative Pharmacokinetics of Nimodipine in Rat Plasma and Tissues Following Intraocular, Intragastric, and Intravenous Administration. AAPS PharmSciTech 2020; 21(6) doi: 10.1208/s12249-020-01772-3
|
| 27 |
Qiuchan Huan, Zhengxian Gao, Peigen Wu, Yingdi Zhang, Haitao Xiao, Jiao Peng. Picroside III, an Active Ingredient of Picrorhiza scrophulariiflora, Ameliorates Experimental Colitis by Protecting Intestinal Barrier Integrity. Chemistry & Biodiversity 2023; 20(6) doi: 10.1002/cbdv.202300572
|
| 28 |
Liqin Ning, Ningyuan Ye, Bai Ye, Zhiwei Miao, Tingting Cao, Weimin Lu, Danhua Xu, Chang Tan, Yi Xu, Jing Yan. Qingre Xingyu recipe exerts inhibiting effects on ulcerative colitis development by inhibiting TNFα/NLRP3/Caspase-1/IL-1β pathway and macrophage M1 polarization. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01361-w
|
| 29 |
Eun Hye Gwak, Hee Young Yoo, So Hee Kim. Effects of Diabetes Mellitus on the Disposition of Tofacitinib, a Janus Kinase Inhibitor, in Rats. Biomolecules & Therapeutics 2020; 28(4): 361 doi: 10.4062/biomolther.2020.006
|
| 30 |
Matthew J Brookes, John Waller, Joseph C Cappelleri, Irene Modesto, Marco D DiBonaventura, Natalie Bohm, Ruth Mokgokong, Olivia Massey, Robert Wood, Danielle Bargo. Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis. BMJ Open Gastroenterology 2020; 7(1): e000456 doi: 10.1136/bmjgast-2020-000456
|
| 31 |
Rachele Del Sordo, Umberto Volta, Vassilios Lougaris, Paola Parente, Angelo Sidoni, Mattia Facchetti, Gabrio Bassotti, Illuminato Carosi, Celeste Clemente, Vincenzo Villanacci. Histological Features of Celiac-Disease-like Conditions Related to Immune Checkpoint Inhibitors Therapy: A Signal to Keep in Mind for Pathologists. Diagnostics 2022; 12(2): 395 doi: 10.3390/diagnostics12020395
|
| 32 |
Danielle Bargo, Theo Tritton, Joseph C. Cappelleri, Marco DiBonaventura, Timothy W. Smith, Takanori Tsuchiya, Sean Gardiner, Irene Modesto, Tim Holbrook, Daniel Bluff, Taku Kobayashi. Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use. Inflammatory Intestinal Diseases 2021; 6(4): 186 doi: 10.1159/000519123
|